VYGR
Voyager TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VYGR Profile
Voyager Therapeutics, Inc.
A gene therapy and neuroscience company developing next-generation adeno-associated virus (AAV) capsids
Biological Technology
--
11/11/2015
NASDAQ Stock Exchange
172
12-31
Common stock
75 Hayden Avenue, Lexington, Massachusetts 02421
--
Voyager Therapeutics, Inc., was incorporated in June 2013 under the laws of the State of Delaware. The company is a biotechnology company dedicated to breaking through gene therapy and neurological barriers. The company's gene therapy platform enables them to design, optimize, manufacture and deliver AAV-based gene therapies that they believe have the potential to safely deliver long-lasting efficacy.
